Arrowhead PharmaceuticalsARWR 
$23.94-3.08%24h
-3.08%24h
Global rank4046
Market cap$2.56B
Change 7d1.14%
YTD Performance-21.51%
SP500 benchmarkUnderperform
P/E-12.47
P/S10.62
Revenue$240.74M
Earnings-$209.28M
Dividend yield-
Main Sector
Healthcare
Arrowhead Pharmaceuticals (ARWR) Total Liabilities
ARWR Total Liabilities in 2022: $478.39M
According to Arrowhead Pharmaceuticals latest financial reports the total liabilities of ARWR is $478.39M, an increase of 74.85% to 2022. At the end of 2022 company had $273.60M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Arrowhead Pharmaceuticals is responsible for during its operational activities.
Arrowhead Pharmaceuticals (ARWR) Total Liabilities History from 2023 to 2022
-
Value:-
ARWR Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $478.39M | 74.85% |
| 2022 | $273.60M | -9.20% |
| 2021 | $301.33M | 396.21% |
| 2020 | $60.73M | -42.61% |
| 2019 | $105.81M | 1761.05% |
| 2018 | $5.69M | - |
View the Top Total Liabilies Stocks
